New Research Points to Possible Alzheimer’s Reversal

A New Angle on Alzheimer’s Disease

Scientists may be rethinking one of the longest-held assumptions about Alzheimer’s disease: that once cognitive decline begins, it cannot be reversed. A new animal study suggests restoring balance to the brain’s energy systems could not only slow the disease—but potentially reverse its effects, at least in laboratory models.

The Role of the Brain’s Energy Supply

The study, led by researchers at University Hospitals Cleveland Medical Center, focused on NAD+, a molecule essential for cellular energy, maintenance, and long-term cell survival. Researchers found that both Alzheimer’s mouse models and human Alzheimer’s brain tissue showed severe declines in NAD+ levels—declines that worsen naturally with age.

When NAD+ drops too low, brain cells struggle to repair themselves and survive. Since the brain consumes roughly 20 percent of the body’s total energy, even small disruptions can have major consequences for cognition.

Reversing Damage in Advanced Alzheimer’s Models

Using an experimental medication called P7C3-A20, researchers restored normal NAD+ levels in mice. The results were striking. In early stages, the drug blocked the onset of Alzheimer’s-like symptoms. In advanced stages, it reversed amyloid and tau buildup and fully restored cognitive function in the animals.

Senior study author Andrew A. Pieper described the findings as a “proof of principle” that some forms of dementia may not be permanently irreversible.

Cautious Optimism—With Important Limits

Experts stress that the findings apply only to animal models. Alzheimer’s is a complex, uniquely human disease, and success in mice does not guarantee the same outcome in people. No treatments have yet been tested in humans with the goal of reversing Alzheimer’s—only slowing its progression.

Researchers also warned against unsupervised use of NAD+-boosting supplements, which may raise levels too high and carry risks.

What This Means Going Forward

While human trials are still needed, the study opens a promising new direction: targeting brain energy balance rather than plaques alone. Combined with proven lifestyle habits—sleep, nutrition, activity, and social engagement—the research offers cautious hope in a field long defined by limits.